Navigation Links
Gut research yields new anti-cancer approach

Researchers believe they have discovered by chance a new way to fight colorectal cancer, and potentially cancers of the esophagus, liver and skin. Early work shows that a group of compounds called peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibitors may have an unexpected cancer-fighting effect, according to research published today in the journal International Cancer Research. Furthermore, the new studies suggest that PPARgamma inhibitors act through some of the same mechanisms as the blockbuster chemotherapy Taxol, but with key differences.

While studying whether compounds known to affect PPARgamma could play a role in inflammatory bowel diseases, a team at the University of Rochester Medical Center found that medium-to-high doses of PPARgamma inhibitor killed colorectal cancer cell lines. Despite the compound's class name, the anti-cancer effect has nothing to do with the ability of the compounds to inhibit PPARgamma function. Researchers believe that PPARgamma inhibitors instead attack the "skeletons" of cancer cells that enable them to reproduce, grow and spread. Better solutions are needed because, according to the American Cancer Society, colorectal cancer remains the no. 2 cause of cancer death for men, and the no. 3 cause of cancer death for women.

"This is the first observation of a small molecule dramatically reducing levels of the proteins called tubulins, the building blocks of cancer cell skeletons," said Katherine L. Schaefer, Ph.D., a research assistant professor within the Department of Medicine, Gastroenterology and Hepatology Division, at the University of Rochester Medical Center, and first author of the paper. "Because cells that line the colon are similar to those in the liver, esophagus and skin, we see potential for a new way to treat those cancers as well."

In the study that led to the discovery of the anti-cancer effect, researchers were looking for new ways to reduce inflammation seen in Crohn'
'"/>

Source:University of Rochester Medical Center


Page: 1 2 3 4

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. U of M researcher examines newly emerging deadly disease
3. NYU researchers simulate molecular biological clock
4. First atlas of key brain genes could speed research on cancer, neurological diseases
5. New research questions basic tenet of neuron function
6. Vital step in cellular migration described by UCSD medical researchers
7. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
8. UCSD researchers maintain stem cells without contaminated animal feeder layers
9. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
10. New protein discovered by Hebrew University researchers
11. First real-time view of developing neurons reveals surprises, say Stanford researchers

Post Your Comments:
(Date:11/3/2009)...ecutives in 35 of the top Fortune 500 companies we...es" in 2008, according to a new type of theoretica...her to determine fair CEO compensation. , "One o...nce issues of the day is how to determine fair pay...n, a professor of chemical engineering. "The propo...
(Date:11/3/2009)...ew and diverse types of garlic is on the rise. Fue...foods" movement, interest in world cuisines, and w...fits, demand for high-quality, locally grown garli... grocery stores in carry the familiar white, "soft...ties of "hardneck" garlic in colorful hues of purp...
(Date:11/3/2009)...ixed reputation. Their delicate, colorful flowers ...home gardeners and growers. But the striking plant...ecipe of light, moisture, warm temperatures, high ...african violets to grow and flower. , A recently...d Janet C. Cole from the Department of Horticultur...
Breaking Biology News(10 mins):New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Sustainably grown garlic 2Sustainably grown garlic 3For African violets, 'hands off' means healthier 2The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 52000 1The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 52000 2The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 52000 3Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 1Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 2Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 3Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 4Ted Karkus Named CEO of The Quigley Corporation 3B Robert V Cuddihy Jr Named Chief Operating Officer 51991 1Ted Karkus Named CEO of The Quigley Corporation 3B Robert V Cuddihy Jr Named Chief Operating Officer 51991 2Ted Karkus Named CEO of The Quigley Corporation 3B Robert V Cuddihy Jr Named Chief Operating Officer 51991 3Ted Karkus Named CEO of The Quigley Corporation 3B Robert V Cuddihy Jr Named Chief Operating Officer 51991 4
...t contain high levels of action, such as Unreal To...earchers at the University of Rochester have shown...ew hours a day over the course of a month improved...letters presented in clutter—a visual acuity test ...ics. , In essence, playing video game improves y...
...l team led by researchers from the National Human ...ional Institutes of Health (NIH), has identified a...all size in dogs. The findings appear in the April...tification and characterization of a key genetic v...s particularly exciting because the underlying gen...
...t St. Jude Children,s Research Hospital have disco...bute to the formation of pediatric acute lymphobla...ldren. The discovery not only suggests novel metho... roadmap for the identification of unsuspected mut...ich immature white blood cells that normally devel...
Other Biology News:Action video games sharpen vision 20 percent 2Researchers identify gene involved in dog size 2Researchers identify gene involved in dog size 3Researchers identify gene involved in dog size 4Major gene study uncovers secrets of leukemia 2Major gene study uncovers secrets of leukemia 3
(Date:11/5/2009)..., AUSTIN, Texas, Nov. 5 SpineSm...GenOsteo, Inc. to co-develop a unique scaffold tha... Following evaluation of several commercial produ...tment, the company believes the GenOsteo scaffold ... that creates a unique and ideal environment for t...
(Date:11/5/2009)... Brooke Sanders brings a n...vine, CA (PRWEB) November 5, 2009 -- Professional ...ng reprographics company is pleased to present Bro...ny as their graphics/PR specialist. The addition o...onsistent growth within Professional Reprographics...
(Date:11/4/2009)..., PETERSBURG, Va., Nov. 4 /PRNewswire-FirstCall...nounced today that the company plans to introduce ...ts subsidiary, Rock Creek Pharmaceuticals, for wor...nVentiv Health, Inc . (Nasdaq: VTIV). inVentiv H... solutions for every stage of the product lifecycl...
(Date:11/4/2009)..., ,, NORRISTOWN, Pa., Nov. 4 /PRNewswire...ceutical solutions company, today announced that i...search , a contract research organization that sp...es, to further extend its business development cap... expertise of industry veteran Robert Westbrook, C...
Breaking Biology Technology:SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4Emerson Resources Forges Strategic Partnership with Bio Research 2
...Adverse Toxic Effects, ATLANTA, Nov. 10 Potentia...ompany developing medicines for the treatment of,a...hase I data last week,during the Retina Subspecial...AO) Annual Meeting in Atlanta, GA. The data was fr...POT-4 Therapy for Patients with Neovascular,Age-Re...
...and Public Health Care ... to help government,entities, hospitals and public...mmunization season, Sentry Logistic Solutions is a...r storage and handling of vaccine,materials. In or...oducts,vaccine storage and distribution functions ...
...sdaq: NGSX ), a biopharmaceutical company focused...gement therapies, announced today that,Anthony DiT...heduled to,present at the Rodman & Renshaw 10th An...sday, November 11, 2008. Mr. DiTonno and Stephen G...ilable to respond to questions,during the breakout...
Other Biology Technology:Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial 2Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial 3Sentry Logistic Solutions Offers Outsourced Vaccine Storage & Distribution Service 2Sentry Logistic Solutions Offers Outsourced Vaccine Storage & Distribution Service 3NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference 3
Bromophenol Blue sodium salt from Sigma-Aldrich
DAPI from KPL
LV-2080 Solvent Switching Valve from JASCO
GelCode Color Silver Stain Kit from Pierce Biotechnology, Inc.
Biology Products: